EQ | Equillium, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.6939 - 0.7220
52 Week Range	0.4800 - 3.25
Beta	1.45
Implied Volatility	474.43%
IV Rank	75.68%
Day's Volume	35,678
Average Volume	196,982
Shares Outstanding	35,430,800
Market Cap	25,442,857
Sector	Healthcare
Industry	Biotechnology
IPO Date	2018-10-12

Valuation
Profitability
Growth
Health
P/E Ratio	-5.98
Forward P/E Ratio	N/A
EPS	-0.12
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	45
Country	USA
Website	EQ

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

EQ's peers: LYRA, HOOK, LIAN, JSPR, CINGW, SABS, ANEB, CVKD, MNPR, SPRO, BOLT, CHRS, GRCL, NLTX, IKNA, HOWL, EWTX, QNRX, KTTA, LIFE, TRVI, CUE, ANTX, BCAB

*Chart delayed

Analyzing fundamentals for EQ we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is very weak. For more detailed analysis please see EQ Fundamentals page.

Watching at EQ technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on EQ Technicals page.